I'm not familiar with this at all, but here's the lay description of 64650-64653. It sounds like they do a series of injections, bilaterally, so it should only be billed once per day. See what you think.
The physician administers a neurotoxin to the eccrine glands to reduce hyperhydrosis (excessive sweating). The skin area to be injected is identified by applying iodine to the skin followed by a light dusting with cornstarch. The resulting chemical change caused by the patientâ€™s perspiration turns the area black. Botulinum toxin type A (BTX-A, BotoxÂ®) is injected intradermally into the site with a series of injections, usually 10 to 15 injections per axilla, via a Teflon-coated 23- to 26-gauge electromyogram (EMG) needle with syringe. Since the sweat glands are between the dermis and the dermal fat tissue, the injections must be precise. BTX-A must be injected deep enough to reach the nerve endings but not so deep as to go into the fat. Report 64650 for eccrine glands of both axillae. Report 64653 for eccrine glands of other body areas.
- ICD-10 Trainings
- Comprehensive Courses
- CPC (Certified Professional Coder)
- COC (Certified Outpatient Coder)
- CIC (Certified Inpatient Coder) NEW!
- CRC (Certified Risk Adjustment Coder) NEW!
- CPB (Certified Professional Biller)
- CPMA (Certified Professional Medical Auditor)
- CDEO (Certified Documentation Expert – Outpatient) NEW!
- CPPM (Certified Physician Practice Manager)
- CPCO (Certified Professional Compliance Officer)
- VIEW ALL CERTIFICATIONS
Coding / Billing Solutions
- Audit / Compliance Solutions
Job Experience / Apprentice Removal
News / Discussion
- Other Resources
- Book Store
- Log In / Join